Cholamandalam faces earnings test after strong profit growth
Cholamandalam Investment and Finance reported first-quarter fiscal 2027 net profit growth of 45.60% to ₹1,656.22 cr. OI Charts data showed the stock down 13.7% over 20 sessions, with long unwinding ahead of the 28 Oct results.
pre-market1 source ↓machine-written, see hownot a recommendation
- CHOLAFIN close
- ₹1,553
- On the day
- -1.36%
- Futures OI, long unwinding
- -1.2%
- Put-call ratio
- 0.85
- Max pain
- ₹1,620
Cholamandalam Investment and Finance Company reported a 45.60% year-on-year increase in first-quarter fiscal 2027 net profit to net profit ₹1,656.22 cr, while revenue rose 21.81% to ₹8,956.68 cr. The next scheduled event is the board meeting on 28 Oct 2026, when it will consider results for the quarter and half-year ended 30 Sep 2026.
The September report will be measured against a stronger earnings base. For the year ended 31 Mar 2026, total income increased 20.60% to ₹31,538.73 cr and net profit rose 22.74% to ₹5,228.88 cr. The comparison is therefore demanding: investors will assess whether the pace of profit growth and revenue expansion remained above the full-year trend in the latest quarter.
OI Charts data for 19 Oct showed the stock at ₹1,553, down 1.36% on the day, with volume of 573,647 shares. The price had declined 1.8% over five sessions and 13.7% over 20 sessions, while remaining above its 52-week low of ₹1,299 recorded on 2 Apr 2026. The 52-week high was ₹1,952 on 6 Aug 2026.
The derivatives setup points to reduced futures exposure ahead of the result. Futures open interest fell 1.2% to 14,169,375 shares, a long unwinding pattern, while the futures premium was almost flat at -0.01%. The put-call ratio was 0.85 and maximum pain stood at ₹1,620 for the 27 Oct 2026 expiry. The largest put open interest was at ₹1,560, close to the latest price, while the largest call open interest was at ₹1,700. 💼
Traders will watch the 28 Oct filing for revenue, profit growth and the direction of the comparison with the strong first quarter. The ₹1,560 put concentration, ₹1,620 maximum-pain level and ₹1,700 call concentration provide key derivatives reference points around the results window. The 27 Oct expiry also falls one session before the scheduled announcement, increasing the importance of the next reported positioning changes.
Source: ad-hoc-news.de, 19 Oct 2026
Not investment advice. For informational purposes only.